BCR-ABL1 Translocation Combined with JAK2(V617F) or CALR(type-1,2) Mutations in Russian CML Patients Undergoing TKI Therapy: Transcript Level and Mutation Allele Burden

Abdullaev A.¹ , Makarik T.¹ , Odilov A. ² , Nikulina E.¹ , Melikyan A.¹ , Turkina A.¹ , Sudarikov A.¹

Clinical Lymphoma, Myeloma and Leukemia

Английский

Опубликовано

20

2020

• ¹ Natl Res Ctr Hematol, Moscow, Russia
• ² Peoples Friendship Univ Russia RUDN Univ, Moscow, Russia

chronic myeloid leukemia; mutation; BCR-ABL1; JAK2V617F; CALR type 1/2; TKI therapy; CML